SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Monogram Biosciences, Inc. (Nasdaq:MGRM) today reported financial results for the quarter ended March 31, 2009. The Company reported revenues of $14.2 million for the first quarter of 2009, compared to $14.8 million in the first quarter of 2008.
